From 2001 to 2005, Azar was the Department of Health and Human Services' general counsel.
President Donald Trump on Monday announced that he is nominating Alex Azar, a former top executive at U.S. pharmaceutical giant Eli Lilly, to be the next Secretary of the Department of Health and Human Services (HHS).
"At a time when the United States pays, by far, the highest prices in the world for prescription drugs, the last thing we need is to put a pharmaceutical executive in charge of the Department of Health and Human Services", Sanders said in a statement.
President Donald Trump has picked a pharma insider to oversee the HHS.
Professionally, Azar has another set of skills that may be valuable to the president. These are goals that the administration, to date, generally has failed to achieve.
Ron Wyden of Oregon, said he would ask for Azar's "commitment to faithfully implement the Affordable Care Act and take decisive, meaningful action to curtail the runaway train of prescription drug costs".
Odebrecht admitió haber tenido vínculo con presidente peruano Kuczynski
Como se recuerda, Marcelo Odebrecht fue entrevistado por un grupo de fiscales para determinar las anotaciones en su agenda, que harían referencia a Keiko Fujimori y Alan García .
UC Browser Disappears From Google Play Store, UCWeb Responds
Unfortunately, one of the company's findings reveals that this kind of malicious software can make a device vulnerable to hacking. There were worries in India that UC Browser was sending information to China, and it won't not be permitted to work in India.
Trump nominará a exejecutivo farmacéutico como secretario de Salud
Se había unido a esa farmacéutica en 2007, tras haber sido número dos del departamento de Salud durante dos años cuando George W.
"He's smart, practical, listens to all sides", Benjamin said, adding, "We've got somebody whose heart is in the right place".
"It's very dangerous to let the perfect be the enemy of the good especially when you have to get 50 people in the U.S. Senate to agree to it", Azar replied. Even though he was steeped in healthcare policy, Price was an outsider to the agency he was sent to run. He clerked for conservative Supreme Court Justice Antonin Scalia and worked for special counsel Kenneth Starr to investigate President Bill Clinton's Whitewater real estate investments.
If confirmed, Azar would join the club of Trump administration officials from big business. Treasury Secretary Steven Mnuchin was a former Goldman Sachs executive and hedge fund manager.
The Trump administration's previous HHS secretary, Dr. Tom Price, resigned on Sept. 29 after reports emerged he had traveled on chartered planes-for work and personal time-at the cost of at least $400,000 to taxpayers.
Mr Trump's pick to lead the Food and Drug Administration, Scott Gottlieb, also faced scrutiny for receiving consulting payments from drugmakers and medical device companies while in the private sector. Once in office, Gottlieb pushed efforts to lower drug prices by reworking FDA drug reviews to increase competition.
Azar has considerable experience navigating the rather confusing health care regulatory environment, which could prove a boon to Trump and congressional Republicans campaign to overhaul the American health care system.
- 8 congresistas investigados por caso Odebrecht
- Murió el pianista y compositor argentino Luis Bacalov
- Maradona y el banco de la Selección: "Yo quiero volver"
- Trump se reunirá con miembros de la Asean en Manila
- Estudiantes pierden el piso durante una fiesta #VIDEO
- Burzaco dijo que pagó coimas a dos funcionarios de Fútbol para Todos
- ¿Es posible un mundial alternativo al de Rusia?
- Capturan a "El Tortillero", operador del Cártel de los Beltrán Leyva
- Conozca las sorprendentes cábalas del 'Profe' Gareca para vencer a Nueva Zelanda
- Rusia y China toman distancia de maniobra de EE.UU. contra Venezuela